Atlas Trials

Yonghong Li

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yonghong Li

RecordFirmDate
Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC (NCT07503379)Yonghong Li2026-04-01
ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide (NCT06865547)Yonghong Li2025-01-22

Track Yonghong Li automatically

Every clearance here is in the API, with alerts when new ones post.